Last night, the Shanghai Pharmaceutical Research Institute announced that they initially discovered that the Chinese patent medicine Shuanghuanglian can "inhibit" the new coronavirus. Subsequently, the Shuanghuanglian oral liquid and other related drugs in most pharmacies were immediately "out of stock" and panic buying.
However, doubts about Shuanghuanglian's ability to "suppress" the virus came out immediately. At present, even Zeng Guang, a senior expert of the National Health Commission, has questioned this matter.
Just now, Zeng Guang posted on his Weibo account:
"Is Shuanghuanglian effective in suppressing the new coronavirus? It should undergo a rigorous clinical pharmacology review. Is it possible that such review will yield results so quickly? I think that the relevant scientific research units that claim that Shuanghuanglian is effective should tell us what verification procedures they have gone through so that they can make a judgment."
Earlier today, the "National is a through train" column on Chinanews.com. Interviewed the Shanghai Institute of Medicine and asked about Shuanghuanglian's ability to "inhibit" the virus.
In this interview, the relevant personnel of the Shanghai Institute of Pharmaceuticals stated that the ability of Shuanghuanglian to "inhibit" the virus is only a "preliminary verification" done on their Wuhan virus, and "there is no detailed study yet."
When asked if there are clinical data, the relevant person said, “I don’t have it here. I don’t know. I can’t answer your question now.”
As for this “preliminary research” of the institute. Regarding the rush to buy Shuanghuanglian, when the reporter asked whether the medicine was really effective, the staff of the institute said, "We can't talk about this problem now." Responsible editor of
: Xue Yilei
copyright works, without the written authorization of huanqiu.com, are strictly forbidden to reprint, and offenders will be held legally responsible.
